A general introduction to the principles of diagnosis and treatment of
children with brain tumors is presented. Molecular characterization of
solid tumors is also presented. Molecular pathways provide putative
targets for new therapies. High resolution magic spinning NMR
spectroscopy is explained, which is used to determine metabolic profiles
for small pieces of intact tissue and whole cells in culture. The
differences between adult and pediatric brain tumors are outlined. It is
emphasized that pediatric low-grade gliomas need lower doses of
antidrugs such as cisplatin/etoposide. It is explained that tumor
suppressor genes and oncogenes play a crucial role in the development
and progression of human malignancies, including those in children.
Neurofibromatosis type-1 is a common genetic disorder with a high
prevalence in CNS abnormalities including tumors in children; which is
discussed in detail. Various neuroradiological imaging modalities in
children with leukemia are detailed. Also are detailed results of
clinical trials in pediatric brain tumors, such as medulloblastoma,
ependymoma, craniopharyngioma, low-grade glioma, high-grade glioma,
brainstem glioma, and germ cell tumors, using radiotherapy. Considering
the clinical importance of epilepsy in the primary brain tumors in
children, its symptoms, diagnosis, and treatments (surgery and
antiepileptic drugs) are discussed.